Absurde Éclairer cette vas narasimhan décès Branche exiler
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
En un an, Vas Narasimhan a réinventé le laboratoire Novartis - Challenges
Novartis CEO says preparedness for a new pandemic has not improved
Vas Narasimhan | MCAAD
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis chief criticises EU move to control pharma licensing in emergencies
Vas Narasimhan on the post-pandemic world - Novartis Live. Magazine
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Bâle est très ouvert aux nouveaux arrivants - Basel Area Business & Innovation
Novartis se réorganise avec l'ambition de réduire ses coûts
Critiqué pour son salaire à 16 millions: Le CEO Vas Narasimhan se fait atomiser à l'assemblée générale de Novartis
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
How to get ordinary people to do extraordinary things: Novartis CEO Vas Narasimhan on the multiplier
It was never my plan to be the boss of a huge company'
Vas Narasimhan (@VasNarasimhan) / X
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Vas Narasimhan | Nature Reviews Drug Discovery
The 'student' of leadership who seeks to inspire his employees
Srishti Gupta with Vas Narasimhan
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Vasant Narasimhan | Novartis
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology